Appearance of Pancreas Predictive of Cancer Presence: Utility of Computed Tomography Volumetry
Background/Objectives: Pancreatic cancer (PC) should be diagnosed in its early stages. Therefore, it is necessary to identify high-risk individuals of PC. Methods: Between 2001 and 2017, 1542 PC cases were diagnosed at two tertial care institutions. Of these, 117 cases had undergone abdominal contrast-enhanced computed tomography (CE-CT) 1–10 years before PC diagnosis and were classified as the PC group. Meanwhile, 43,102 cases underwent abdominal CE-CT for close examination of non-pancreatic diseases in the same period, of which 1170 were randomly selected. Of these, 117 cases were matched to the PC group with the propensity score and designated the non-PC group. Pancreatic volumetry was performed using the 3D image analysis system for abdominal CE-CT in both groups and various measurements were compared. In PC group, CE-CT taken 1–10 years before the onset of PC was analyzed. Results: After propensity score matching, baseline characteristics did not significantly differ between the two groups. The whole pancreatic volume/body surface area (BSA) (p = 0.014), volume of main pancreatic duct (MPD) plus cystic lesion/BSA (p < 0.001), volume of pancreatic parenchyma/BSA (p = 0.002), ratio of cross-sectional areas (p = 0.033), and MPD diameter/BSA (p < 0.001) significantly differed between the two groups. In subgroup analysis of patients without cystic lesions, the whole pancreatic volume/BSA, volume of MPD/BSA, volume of pancreatic parenchyma/BSA, ratio of cross-sectional areas, and MPD diameter/BSA significantly differed between the two groups. Conclusions: Pancreatic volumetry could identify patients at high risk of PC.
Authors
- Hiromu Morishita (ORCID: https://orcid.org/0009-0007-8086-7841)
- Takahiro Shishimoto (ORCID: https://orcid.org/0009-0007-6214-3065)
- Shunsuke Omoto (ORCID: https://orcid.org/0000-0001-7291-3608)
- Akiya Nakahata (ORCID: https://orcid.org/0009-0007-1812-2726)
- Tomokazu Ishihara (ORCID: https://orcid.org/0009-0007-0807-2948)
- Takashi Tamura (ORCID: https://orcid.org/0000-0002-5611-2509)
- Yuki Kawaji (ORCID: https://orcid.org/0000-0001-8179-2641)
- Yasunobu Yamashita (ORCID: https://orcid.org/0000-0002-6725-5708)
- Ke Wan (ORCID: https://orcid.org/0000-0002-1563-7181)
- Kentaro Yamao
- Yuto Sugihara
- Masahiro Itonaga
- Masayuki Kitano (ORCID: https://orcid.org/0000-0001-6885-9223)
- Reiko Ashida
- Mamoru Takenaka (ORCID: https://orcid.org/0000-0001-7308-4311)
Institutions
- Wakayama Medical University (JP)
- Kindai University Hospital (JP)
- Nagoya University (JP)
- Kindai University (JP)
Publication Details
- Journal
- Cancers
- Published
- 2026-05-22
- DOI
- https://doi.org/10.3390/cancers18111684
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00